It is a big concern for every cancer patient to decide
whether he/she could or should or would take any medicine
when undergoing radiotherapy.
Even doctors are sometimes confused and they cannot
tell their patients whether a herbal will do more
harm than good. On the Internet all Tian Xian selling
websites (like www.tianxian.co.uk or www.tianxian.com)
only state that it is good to take Tian Xian together
with an ongoing radiotherapy. But where is the evidence?
In a publication written by Prof. Wang Zhen Guo we
came across these experiments that have been conducted
on Tian Xian together with radiotherapy. It should
show (proof) that Tian Xian Liquid supports radiotherapy
and (maybe) could help to make the same more effective.
Tian Xian Liquid in combination with radiotherapy:
Under the state of random control, all three cases
of Tian Xian Liquid in combination with different
dosage radiotherapy on mid or final stage carcinoma
of esophagus showed apparent enhanced sensitivity.
Tian Xian Liquid to radiotherapy's enhanced sensitivity
might mainly come from both the drug and radiation.
(Table 5-8). Since Tian Xian Liquid has apparent inhibition
on carcinoma of esophagus and as might be predict
from this, Tian Xian Liquid is possible to become
a valuable enhanced sensitivity of radiation.
Table
5: Curing effects of combined use of Tian Xian
Liquid 900ml compared to single use at DT 4000cgy
(P<0.01) case |
Effect |
CR |
PS |
S |
P |
Relief
Rate |
Group\Case |
Case
% |
Case
% |
Case
% |
Case
% |
Case
% |
Esperimental
group |
6
30 |
10
50 |
4
20 |
0 |
16
80 |
Control
group |
1
5 |
8
40 |
8
40 |
3
15 |
9
45 |
Table
6 DT 4000cgy combined use of Tian Xian Liquid
(1350ml) compared to single use at DT 6000cgy-7500cgy
(P<0.05) case |
Effect |
CR |
PS |
S |
P |
Relief
Rate |
Group\Case |
Case
% |
Case
% |
Case
% |
Case
% |
Case
% |
Esperimental
group |
11
55 |
5
25 |
4
20 |
0 |
16
80 |
Control
group |
6
30 |
6
30 |
8
20 |
0 |
12
60 |
Table
7 Combined use of TXL 1350ml compared to single
use DT 6000cgy-7500cgy (P=0.01) case |
Effect |
CR |
PS |
S |
P |
Relief
Rate |
Group\Case |
Case
% |
Case
% |
Case
% |
Case
% |
Case
% |
Esperimental
group |
13
65 |
6
30 |
1
5 |
0 |
19
95 |
Control
group |
6
30 |
6
30 |
8
40 |
0 |
12
60 |
Table
8 Curing effects on mid or final stage carcinoma
of esophgus of combined use of TXL 900ml compared
to single use at DT 4000cgy |
Effect |
CR |
PS |
S |
P |
Relief
Rate |
Group\Case |
Case
% |
Case
% |
Case
% |
Case
% |
Case
% |
Esperimental
group |
18
42.0 |
12
28.6 |
12
28.6 |
0 |
30
71.4 |
Control
group |
2
4.8 |
3
7.1 |
17
40.5 |
20
47.6 |
5
11.9 |
| The
curative ratio on carcinoma of esophagus of radiotherapy
had been increased 28.3% by Tian Xian Liquid through
clinical tests. |
